Ernexa Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Ernexa Therapeutics Inc. has filed 1,511 SEC EDGAR filings since 14 Feb 1994

SEC filing history

Showing 76-100 of 258 matching filings.

Per page
25
Current page
4
8-K File 001-11460

8-K

Filing date
14 Jun 2021
Reporting date
13 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K

Filing date
10 Jun 2021
Reporting date
05 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K

Filing date
26 May 2021
Reporting date
20 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K

Filing date
11 May 2021
Reporting date
06 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-11460

8-K/A

Filing date
30 Apr 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K

Filing date
30 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K

Filing date
23 Apr 2021
Reporting date
21 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K

Filing date
16 Apr 2021
Reporting date
12 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K

Filing date
15 Apr 2021
Reporting date
09 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K

Filing date
07 Apr 2021
Reporting date
01 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K

Filing date
31 Mar 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K filing

Filing date
23 Mar 2021
Reporting date
23 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .